Efficacy and safety of glecaprevir/pibrentasvir in patients infected with HCV GT1-3 by renal impairment status: A pooled analysis of two phase 3 Japanese trials

Authors
Category Primary study
JournalHepatology
Year 2017
This article has no abstract
Epistemonikos ID: 5c5c7d27298020b1960ec1ad9992b991c598bfb7
First added on: Feb 08, 2025